Global cardiovascular and renal outcomes of reduced GFR

Journal of the American Society of Nephrology

Volumn 28, Issue 7, 2017, Pages 2167-2179

  Thomas, Bernadette ^a,b   Matsushita, Kunihiro ^c   Abate, Kalkidan Hassen ^d   Al Aly, Ziyad ^e   Ärnlöv, Johan ^f,g   Asayama, Kei ^h   Atkins, Robert ⁱ   Badawi, Alaa ^j,k   Ballew, Shoshana H ^c   Banerjee, Amitava ^l   Barregård, Lars ^m   Barrett Connor, Elizabeth ⁿ   Basu, Sanjay ^p   Bello, Aminu K ^q   Bensenor, Isabela ^r   Bergstrom, Jaclyn ⁿ   Bikbov, Boris ^s   Blosser, Christopher ^b   Brenner, Hermann ^t   Carrero, Juan Jesus ^f   Chadban, Steve ^u,v,w   Cirillo, Massimo ^x   Cortinovis, Monica ^y   Courville, Karen ^y   Dandona, Lalit ^a,z   Dandona, Rakhi ^a,z   Estep, Kara ^a   Fernandes, João ^aa   Fischer, Florian ^ab   Fox, Caroline ^ac   Gansevoort, Ron T ^ad   Gona, Philimon N ^ae   Gutierrez, Orlando M ^af   Hamidi, Samer ^ai   Hanson, Sarah Wulf ^a   Himmelfarb, Jonathan ^b   Jassal, Simerjot K ^o   Jee, Sun Ha ^aj   Jha, Vivekanand ^ak,al   Jimenez Corona, Aida ^am,an   Jonas, Jost B ^ao   Kengne, Andre Pascal ^ap,aq   Khader, Yousef ^ar   Khang, Young Ho ^as   Kim, Yun Jin ^at   Klein, Barbara ⁿ   Klein, Ronald ^au   Kokubo, Yoshihiro ^av   Kolte, Dhaval ^aw   Lee, Kristine ^ax   Levey, Andrew S ^ay   Li, Yongmei ^az   Lotufo, Paulo ^r   El Razek, Hassan Magdy Abd ^az   Mendoza, Walter ^ba   Metoki, Hirohito ^bb   Mok, Yejin ^aj   Muraki, Isao ^bc,bh   Muntner, Paul M ^bi   Noda, Hiroyuki ^bd,bj   Ohkubo, Takayoshi ^h   Ortiz, Alberto ^be   Perico, Norberto ^y   Polkinghorne, Kevan ^bf,bg   Al Radaddi, Rajaa ^bh   Remuzzi, Giuseppe ^y,ag,bj   Roth, Gregory ^a   Rothenbacher, Dietrich ^bk   Satoh, Michihiro ^bb   Saum, Kai Uwe ^t   Sawhney, Monika ^bl   Schöttker, Ben ^t,bm   Shankar, Anoop ⁿ   Shlipak, Michael ^ay   Silva, Diego Augusto Santos ^bn   Toyoshima, Hideaki ^bo   Ukwaja, Kingsley ^bp   Umesawa, Mitsumasa ^bq   Vollset, Stein Emil ^a,br,bs   Warnock, David G ^ah,bn   Werdecker, Andrea ^bt   Yamagishi, Kazumasa ^bu   Yano, Yuichiro ^bv   Yonemoto, Naohiro ^bw   Zaki, Maysaa El Sayed ^az   Naghavi, Mohsen ^a   Forouzanfar, Mohammad H ^a   Murray, Christopher J L ^a   Coresh, Josef ^c   Vos, Theo ^a   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JIMMA UNIVERSITY   (Ethiopia)

^e WASHINGTON UNIVERSITY   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g DALARNA UNIVERSITY   (Sweden)

^h TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^j PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF GOTHENBURG   (Sweden)

ⁿ San Diego ^*  (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p STANFORD UNIVERSITY   (United States)

^q UNIVERSITY OF ALBERTA   (Canada)

^r UNIVERSITY OF SÃO PAULO   (Brazil)

^s SHUMAKOV NATIONAL MEDICAL RESEARCH CENTER OF TRANSPLANTOLOGY AND ARTIFICIAL ORGANS   (Russian Federation)

^t GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^u Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^v UNIVERSITY OF SYDNEY   (Australia)

^w ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^x UNIVERSITY OF SALERNO   (Italy)

^y MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^z PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^aa CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

^ab BIELEFELD UNIVERSITY   (Germany)

^ac NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^ad UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ae UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^af Duke University Trent Drive   (United States)

^ag Departments of Epidemiology   (United States)

^ah and Clinical Center   (United States)

^ai HAMDAN BIN MOHAMMED SMART UNIVERSITY   (United Arab Emirates)

^aj Yonsei University   (South Korea)

^ak GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^al UNIVERSITY OF OXFORD   (United Kingdom)

^am Institute of Ophthalmology Foundation Conde de Valencia   (Mexico)

^an Mexican Health Ministry   (Mexico)

^ao UNIVERSITY OF HEIDELBERG   (Germany)

^ap SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^aq UNIVERSITY OF CAPE TOWN   (South Africa)

^ar JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^as Seoul National University College of Medicine   (South Korea)

^at Southern University College   (Malaysia)

^au UNIVERSITY OF WISCONSIN MADISON   (United States)

^av NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^aw BROWN UNIVERSITY   (United States)

^ax TUFTS MEDICAL CENTER   (United States)

^ay SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^az MANSOURA UNIVERSITY   (Egypt)

^ba UNITED NATIONS POPULATION FUND   (United States)

^bb TOHOKU UNIVERSITY   (Japan)

^bc Osaka Center for Cancer and Cardiovascular Diseases Prevention   (Japan)

^bd OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^be Instituto de Investigación Sanitaria Fundación Jiménez Díaz   (Spain)

^bf MONASH MEDICAL CENTRE   (Australia)

^bg MONASH UNIVERSITY   (Australia)

^bh MINISTRY OF HEALTH   (Saudi Arabia)

^bi Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

^bj UNIVERSITY OF MILAN   (Italy)

^bk UNIVERSITY OF ULM   (Germany)

^bl MARSHALL UNIVERSITY   (United States)

^bm FOM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^bn FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^bo ANJO KOSEI HOSPITAL   (Japan)

^bp FEDERAL TEACHING HOSPITAL   (Nigeria)

^bq IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^br NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^bs UNIVERSITY OF BERGEN   (Norway)

^bt FEDERAL INSTITUTE FOR POPULATION RESEARCH   (Germany)

^bu UNIVERSITY OF TSUKUBA   (Japan)

^bv NORTHWESTERN UNIVERSITY   (United States)

^bw KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DEATH; DIET RESTRICTION; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UNCERTAINTY; CARDIOVASCULAR DISEASES; GLOBAL HEALTH; KIDNEY; KIDNEY DISEASES; PATHOPHYSIOLOGY; RISK ASSESSMENT;

CARDIOVASCULAR DISEASES; GLOBAL HEALTH; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; RISK ASSESSMENT; RISK FACTORS;

EID: 85021768228     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016050562     Document Type: Article

References (50)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
2. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 11: 156-163, 2007
3. Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U: The epidemiology of chronic kidney disease in sub-Saharan Africa: A systematic review and meta-analysis. Lancet Glob Health 2: e174-e181, 2014
4. Anand S, Shivashankar R, AliMK, Kondal D, Binukumar B,Montez-Rath ME, Ajay VS, Pradeepa R, Deepa M, Gupta R, Mohan V, Narayan KM, Tandon N, Chertow GM, Prabhakaran D; CARRS Investigators: Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease. Kidney Int 88: 178-185, 2015
5. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, KutnerN, Liu J, St PeterW, Ding S,Guo H, Kats A, Lamb K, Li S, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B,Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: US Renal Data System2012 Annual Data Report. Am J Kidney Dis 61[Suppl 1]: A7, e1-e476, 2013
6. Teerawattananon Y, Luz A, Pilasant S, Tangsathitkulchai S, Chootipongchaivat S, Tritasavit N, Yamabhai I, Tantivess S: How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings? Health Res Policy Syst 14: 21, 2016
7. Jha V: Current status of chronic kidney disease care in southeast Asia. Semin Nephrol 29: 487-496, 2009
8. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A, Neaton J, Svendsen K, Mann JF, Yusuf S, Teo KK, Gao P, Nelson RG, Knowler WC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 79: 1341-1352, 2011
9. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081, 2010
10. Hui X, Matsushita K, Sang Y, Ballew SH, F?l?p T, Coresh J: CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: Interactions with age, sex, and race. Am J Kidney Dis 62: 691-702, 2013
11. Agarwal S, Shlipak MG, Kramer H, Jain A, Herrington DM. The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events:Multiethnic study of atherosclerosis. Cardiol Res Pract 2012: 806102, 2012
12. Fried LF, ShlipakMG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41: 1364-1372, 2003
13. Ix JH, ShlipakMG, ChertowGM,WhooleyMA: Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation 115: 173-179, 2007
14. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41: 47-55, 2003
15. Couser WG, Remuzzi G, Mendis S, Tonelli M: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80: 1258-1270, 2011
16. Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, PostmaMJ; Prevention of Renal and Vascular End Stage Disease Study Group: Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease:Costeffectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. Clin Ther 32: 1103-1121, 2010
17. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, et al.; GBD 2013 Risk Factors Collaborators: Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 386: 2287-2323, 2015
18. Barquera S, Pedroza-Tob?as A, Medina C, Hern?ndez-Barrera L, Bibbins-Domingo K, Lozano R, Moran AE: Global overview of the epidemiology of atherosclerotic cardiovascular disease. ArchMed Res 46: 328-338, 2015
19. Moran AE, ForouzanfarMH, RothGA, MensahGA, EzzatiM, Flaxman A, Murray CJ, Naghavi M: The global burden of ischemic heart disease in 1990 and 2010: The Global Burden of Disease 2010 study. Circulation 129: 1493-1501, 2014
20. GBD 2013 Mortality and Causes of Death Collaborators: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385: 117-171, 2015
21. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, StevensGA, Riley LM, Lu Y, Rao M, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group: The global cardiovascular risk transition: Associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation 127: 1493-502, 502e1-8, 2013
22. Shepard D, VanderZanden A, Moran A, Naghavi M, Murray C, Roth G: Ischemic heart disease worldwide, 1990 to 2013: Estimates from the Global Burden of Disease Study 2013. Circ CardiovascQualOutcomes 8: 455-456, 2015
23. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V: Worldwide access to treatment for endstage kidney disease: A systematic review. Lancet 385: 1975-1982, 2015
24. Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M: Maintenance dialysis throughout the world in years 1990 and 2010. J AmSocNephrol 26: 2621-2633, 2015
25. Jim?nez-Cruz A, Bacardi-Gascon M: The fattening burden of type 2 diabetes on Mexicans: Projections from early growth to adulthood. Diabetes Care 27: 1213-1215, 2004
26. Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, Islam N, Bravo RF, Aleckovic-Halilovic M, Zou H, Zhang L, Gouda Z, Tchokhonelidze I, Abraham G, Mahdavi-Mazdeh M, Gallieni M, Codreanu I, Togtokh A, Sharma SK, Koirala P, Uprety S, Ulasi I, Remuzzi G: Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): A cross-sectional study. Lancet Glob Health 4: e307-e319, 2016
27. Popkin BM, Adair LS, Ng SW: Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 70: 3-21, 2012
28. Gupta N, Shah P, Nayyar S, Misra A: Childhood obesity and the metabolic syndrome in developing countries. Indian J Pediatr 80[Suppl 1]: S28-S37, 2013
29. Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman JL,Magnus A, Cobiac L, Betram M, Wallace A: Assessing Cost-effectiveness in Prevention (ACE-Prevention): Final Report, 2010. Available at: https://public-health.uq.edu.au/filething/get/1836/ACE-Prevention-final-report.pdf. Accessed February 22, 2017
30. CrewsDC, Boulware LE,Gansevoort RT, Jaar BG: Albuminuria: Is it time to screen the general population? Adv Chronic Kidney Dis 18: 249-257, 2011
31. Wetmore JB, Collins AJ: Meeting the world's need for maintenance dialysis. J Am Soc Nephrol 26: 2601-2603, 2015
32. PericoN, Plata R, Anabaya A, Codreanu I, Schieppati A, Ruggenenti P, Remuzzi G: Strategies for national health care systems in emerging countries: The case of screening and prevention of renal disease progression in Bolivia. Kidney Int Suppl (97): S87-S94, 2005
33. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstr?m B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gr?nhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 377: 2181-2192, 2011
34. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, HillisGS, Chalmers J,Mant J, SalamA, Rahimi K, Perkovic V, Rodgers A: Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis. Lancet 387: 435-443, 2016
35. Kim SS, Kim JH, Kim IJ: Current challenges in diabetic nephropathy: Early diagnosis and ways to improve outcomes. Endocrinol Metab (Seoul) 31: 245-253, 2016
36. Lunyera J, Mohottige D, Von Isenburg M, JeulandM, Patel UD, Stanifer JW: CKD of uncertain etiology: A systematic review. Clin J Am Soc Nephrol 11: 379-385, 2016
37. Rodr?guez MI: Sounding the alarmon chronic kidney disease in farming communities: Mar?a Isabel Rodr?guez MD. Minister of health, El Salvador. Interview by Conner Gorry. MEDICC Rev 15: 8-10, 2013
38. van Olmen J, Eggermont N, van Pelt M, Hen H, de Man J, Schellevis F, Peters DH, Bigdeli M: Patient-centred innovation to ensure access to diabetes care in Cambodia: The case of MoPoTsyo. J Pharm Policy Pract 9: 1, 2016
39. Thomas B, van Pelt M, Mehrotra R, Robinson-Cohen C, LoGerfo J: An estimation of the prevalence and progression of chronic kidney disease in a rural diabetic cambodian population. PLoS One 9: e86123, 2014
40. Van Olmen J, Marie KG, Christian D, Clovis KJ, Emery B, Maurits VP, Heang H, Kristien VA, Natalie E, Fran?ois S, Guy K: Content, participants and outcomes of three diabetes care programmes in three low and middle income countries. Prim Care Diabetes 9: 196-202, 2015
41. Weaver VM, Fadrowski JJ, Jaar BG: Global dimensions of chronic kidney disease of unknown etiology (CKDu): A modern era environmental and/or occupational nephropathy? BMC Nephrol 16: 145, 2015
42. Garc?a-Trabanino R, Jarqu?n E, Wesseling C, Johnson RJ,Gonz?lez-Quiroz M, Weiss I, Glaser J, Jos? Vindell J, Stockfelt L, Roncal C, Harra T, Barregard L: Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador-A cross-shift study of workers at risk of Mesoamerican nephropathy. Environ Res 142: 746-755, 2015
43. Correa-Rotter R, Wesseling C, Johnson RJ: CKD of unknown origin in Central America: The case for a Mesoamerican nephropathy. Am J Kidney Dis 63: 506-520, 2014
44. Wimalawansa SJ: Escalating chronic kidney diseases of multi-factorial origin (CKD-mfo) in Sri Lanka: Causes, solutions, and recommendations-update and responses. Environ Health Prev Med 20: 152-157, 2015
45. Jha V, Garcia-GarciaG, Iseki K, Li Z, Naicker S, Plattner B, Saran R,Wang AY, Yang CW: Chronic kidney disease: Global dimension and perspectives. Lancet 382: 260-272, 2013
46. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GW, Muntner P, Roderick P, Sairenchi T, Sch?ttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, ?rnl?v J; CKD Prognosis Consortium: Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 3: 514-525, 2015
47. Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H,Wang H: Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: A Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis 67: 728-741, 2015
48. Hill AB: The environment and disease: association or causation? Proc R Soc Med 58: 295-300, 1965
49. Miettinen OS: Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 99: 325-332, 1974
50. Matsushita K, Ballew SH, Astor BC, Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A,Wen CP, Woodward M, Coresh J; Chronic Kidney Disease Prognosis Consortium: Cohort profile: The chronic kidney disease prognosis consortium. Int J Epidemiol 42: 1660-1668, 2013